Business | Edited by Peter Noronha | Thursday November 19, 2020
Gland Pharma's Rs 6,480 crore initial public offering (IPO) had received a muted response; It was subscribed by a mere 2.06 per cent, receiving bids for 6,21,55,670 shares as against the issue size of 3,02,37,879 shares.
www.ndtv.com/business